This mid-cap pharmaceutical stock has been consistently taking support on the rising trendline. This can trigger a potential upmove in the stock by close to 6%, making the current levels attractive to enter with a favorable risk-reward ratio.118664761After facing resistance near Rs. 1,352 in December last year, the stock price of Suven Pharmaceuticals Limited (SUVENPHAR) witnessed a corrective decline. While moving lower, it breached the 50-day